51 studies found for:    NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Download search resultsDownload the search results for:
NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus (51 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
2 Recruiting Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Conditions: MUD Transplant;   AlloPBSC;   Congenital Immunodeficiencies;   HLA Matched Transplant;   BMT
Interventions: Drug: Busulfan;   Drug: Campath-1 H;   Drug: Sirolimus;   Procedure: BMT;   Procedure: Apheresis;   Procedure: Total Body Irradiation;   Procedure: GCSF Injections
3 Recruiting Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Conditions: Food Hypersensitivity;   Eosinophilia;   Peanut Hypersensitivity;   Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention:
4 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
5 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Conditions: Atopic Dermatitis;   Netheron's Syndrome;   Piebaldism;   Hyper IgE Syndrome;   Ichthyosis;   Anaphylaxis;   Severe Allergy
Intervention:
6 Recruiting Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics
Conditions: Chronic Disease;   Healthy;   Lyme Arthritis;   Lyme Disease;   Multiple Sclerosis
Intervention:
7 Recruiting Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Condition: Diabetes Mellitus, Type I
Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD);   Drug: Heparin;   Drug: CellCept® (Mycophenolate mofetil) OR Rapamune® (Sirolimus);   Drug: Prograf® (Tacrolimus) OR Cyclosporine;   Drug: Thymoglobulin® (Anti-thymocyte Globulin) - at first transplant;   Drug: Simulect® (Basiliximab) - at 2nd or 3rd transplant;   Drug: Klexane® (Enoxaparinsodium);   Drug: Trombyl® or Albyl-E® (Acetylsalicylicacid- ASA);   Drug: Enbrel® (Etanercept)
8 Recruiting Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients
Condition: Kidney Transplantation
Intervention:
9 Recruiting Collection of Samples and Data for the National Marrow Donor Program Repository
Condition: Hematopoietic Stem Cell Transplantation
Intervention:
10 Recruiting Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
Condition: Inflammatory Disorder
Intervention:
11 Recruiting Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Conditions: Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention: Drug: sirolimus
12 Recruiting Efficacy of Islet After Kidney Transplantation
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Islet transplant
13 Recruiting Asthma Phenotypes in the Inner City
Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
14 Recruiting A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: abatacept;   Drug: Placebo
15 Recruiting Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma and in Healthy, Non-asthmatic Control Subjects.
Condition: Asthma
Intervention: Biological: GMP-grade HRV-39
16 Recruiting Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Condition: Asthma
Interventions: Biological: Omalizumab;   Drug: Fluticasone;   Biological: Placebo omalizumab;   Biological: Placebo fluticasone
17 Recruiting Viral Triggers in Pediatric Lung Transplantation
Conditions: Lung Transplant;   Bronchiolitis Obliterans;   Obliterative Bronchiolitis
Intervention:
18 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
19 Recruiting Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Condition: Kidney Transplant
Interventions: Drug: Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal;   Drug: MMF/Tacrolimus/Prednisone
20 Recruiting Optimization of NULOJIX® (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Condition: Pancreas and Kidney Transplant
Interventions: Biological: Belatacept;   Drug: Medrol;   Biological: Anti-thymocyte Globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years